These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37709251)

  • 1. Chronic inflammation promotes cancer progression as a second hit.
    Burocziova M; Grusanovic S; Vanickova K; Kosanovic S; Alberich-Jorda M
    Exp Hematol; 2023 Dec; 128():30-37. PubMed ID: 37709251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Transformation Involving
    Olofsen PA; Fatrai S; van Strien PMH; Obenauer JC; de Looper HWJ; Hoogenboezem RM; Erpelinck-Verschueren CAJ; Vermeulen MPWM; Roovers O; Haferlach T; Jansen JH; Ghazvini M; Bindels EMJ; Schneider RK; de Pater EM; Touw IP
    Cell Rep Med; 2020 Aug; 1(5):100074. PubMed ID: 33205068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis in patients with hematologic malignancies].
    Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
    Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
    Beekman R; Valkhof MG; Sanders MA; van Strien PM; Haanstra JR; Broeders L; Geertsma-Kleinekoort WM; Veerman AJ; Valk PJ; Verhaak RG; Löwenberg B; Touw IP
    Blood; 2012 May; 119(22):5071-7. PubMed ID: 22371884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
    Jafek JL; Shakya A; Tai PY; Ibarra A; Kim H; Maddox J; Chumley J; Spangrude GJ; Miles RR; Kelley TW; Tantin D
    Exp Hematol; 2019 Aug; 76():38-48.e2. PubMed ID: 31295506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers.
    Gasparetto M; Smith CA
    Chem Biol Interact; 2017 Oct; 276():46-51. PubMed ID: 28645468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation.
    Reikvam H; Hatfield KJ; Fredly H; Nepstad I; Mosevoll KA; Bruserud Ø
    Eur Cytokine Netw; 2012; 23(4):140-53. PubMed ID: 23328436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
    Zhang J; Kong G; Rajagopalan A; Lu L; Song J; Hussaini M; Zhang X; Ranheim EA; Liu Y; Wang J; Gao X; Chang YI; Johnson KD; Zhou Y; Yang D; Bhatnagar B; Lucas DM; Bresnick EH; Zhong X; Padron E; Zhang J
    Blood; 2017 Jan; 129(3):358-370. PubMed ID: 27815262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of myeloid malignancies.
    Kitamura T; Inoue D; Okochi-Watanabe N; Kato N; Komeno Y; Lu Y; Enomoto Y; Doki N; Uchida T; Kagiyama Y; Togami K; Kawabata KC; Nagase R; Horikawa S; Hayashi Y; Saika M; Fukuyama T; Izawa K; Oki T; Nakahara F; Kitaura J
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):389-404. PubMed ID: 25504228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in understanding the biology and genetics of acute myelocytic leukemia.
    McKenzie SB
    Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
    Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
    Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.
    Botezatu L; Michel LC; Helness A; Vadnais C; Makishima H; Hönes JM; Robert F; Vassen L; Thivakaran A; Al-Matary Y; Lams RF; Schütte J; Giebel B; Görgens A; Heuser M; Medyouf H; Maciejewski J; Dührsen U; Möröy T; Khandanpour C
    Exp Hematol; 2016 Aug; 44(8):713-726.e14. PubMed ID: 27216773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
    Dembitz V; Lalic H; Kodvanj I; Tomic B; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    BMC Cancer; 2020 Nov; 20(1):1090. PubMed ID: 33176741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.